Download or read book Suicide COVID 19 and Ketamine written by Johnathan Edwards and published by . This book was released on 2021-08-15 with total page 300 pages. Available in PDF, EPUB and Kindle. Book excerpt: Why a book about suicide, COVID-19, and Ketamine? These delicate topics are more inter-related than you might think. The World Health Organization (WHO) estimates that each year 800,000 people die from suicide. But have you wondered about the long-term unintended consequences of COVID-19? The deluge of mental-health problems like depression, suicide, and drug overdoses resulting from the pandemic. Depression, suicide and drug overdoses have been a problem since long before the pandemic. But COVID-19 has made the situation worse: it is more of a crisis than a pandemic. Lockdowns have fueled a litany of tragedies: suicides, drug overdoses, heightened crime, starvation, financial ruin, and much more. Adolescent and adult mental illness have skyrocketed during the crisis, and the tsunami of post-traumatic stress, depression, and suicides will follow. The mental-health consequences will persist long after the COVID-19 pandemic ends. Because of the lockdowns, we expect millions of people will die of hunger and postponed medical treatments, a potential outcome that, unfortunately, has developed less notice. The result is a "perfect storm" of suicides and drug overdose deaths. Mental-health practitioners are employing everything, including telemedicine, to help people battle this threat. Suicide is subtle, and the decision to take your own life is often impulsive. The treatment of suicide and depression is complex, with current medications taking weeks or months to work. When a loved one commits suicide, they leave many unanswered questions. Constant thoughts of "what" and "why," permeate the minds of those left behind. We do not have many effective treatments for suicide. But there is one drug that can often stop suicide in its tracks: ketamine. Few are aware that this decades-old anesthetic and party drug might save your loved one's or even your life. Our goal is to convince you ketamine is a legitimate path to treat mental disorders. Simply said, ketamine works. If your loved one was suicidal, would you suggest trying ketamine? Or use it yourself?

Download or read book The Revolutionary Ketamine written by Johnathan Edwards and published by Simon and Schuster. This book was released on 2023-07-11 with total page 286 pages. Available in PDF, EPUB and Kindle. Book excerpt: This isn't a new drug, but it's now being used to treat depression with amazing results. What exactly is it? Is it safe? Is it right for you or your loved one? Suicide captures everyone’s attention. Suicide is a tragedy usually preceded by plenty of pain. About 1 million go through with the act each year. Imagine if your loved one is determined to end their life, and you could get them help. After reading Revolutionary Ketamine, you will understand: Suicide’s devastating cost to society and how to prevent it Why children and adolescents are committing suicide How ketamine stops suicide in its tracks Suicide is the stuff of other people’s nightmares until it happens to someone you love. Time simply stops, leaving you wondering what could have been done. Suicidal ideations hijack our brains, telling us to end our lives prematurely. What if we could remove this hijacking device? Ketamine is the one drug we have today that can safely halt suicidal ideations, yet most have never heard of it. To those who say more studies are needed to know if ketamine helps with suicidal ideations and depression, I offer you this admonition before trying the drug. If you are suffering from depression and suicidal ideations, the risk versus reward is clearly in favor of using ketamine now. Don’t wait. Dr. Edwards, the author of Revolutionary Ketamine, is committed to helping those who need never become statistics at all and will equip you with the tools to save your loved one’s life, or possibly your own.

Download or read book Ketamine for Treatment Resistant Depression written by Sanjay J. Mathew and published by Springer. This book was released on 2016-11-25 with total page 167 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.

Download or read book Suicide Phenomenology and Neurobiology written by Keri E. Cannon and published by Springer. This book was released on 2014-10-06 with total page 309 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book addresses the phenomenology, demographics, and neurobehavioral aspects of suicidal behavior and its risk factors, underscoring common neurobehavioral threads among different approaches which may underlie such extreme behavior. It additionally provides an overview of new approaches, such as imaging techniques to identify at-risk individuals or in response to drug treatment associated with suicidal behavior, neurodevelopmental approaches, genetic and epigenetic linkages to suicidal behavior, animal models of specific risk factors, as well as potential biomarkers being employed to help assess risk.

Download or read book Suicide Risk Assessment and Prevention written by Maurizio Pompili and published by Springer Nature. This book was released on 2022-12-19 with total page 1479 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book explores suicide prevention perspectives from around the world, considering both professionals’ points of view as well as first-person accounts from suicidal individuals. Scholars around the globe have puzzled over what makes a person suicidal and what is in the minds of those individuals who die by suicide. Most often the focus is not on the motives for suicide, nor on the phenomenology of this act, but on what is found from small cohorts of suicidal individuals. This book offers a tentative synthesis of a complex phenomenon, and sheds some light on models of suicide that are less frequently encountered in the literature. Written by international experts, it makes a valuable contribution to the field of suicidology that appeals to a wide readership, from mental health professionals to researchers in suicidology and students.

Download or read book Rheumatology in Questions written by Haralampos M. Moutsopoulos and published by Springer. This book was released on 2018-02-13 with total page 184 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book covers all fields in rheumatology and aims to help readers comprehend, familiarize and evaluate their knowledge of the subject area. It contains short questions and concise answers on definitions, pathogenetic aspects, clinical and laboratory manifestations, differential diagnosis and the management of all rheumatic diseases. The book also provides questions and answers on major aspects of basic immunology, valuable for understanding underlying immunological mechanisms of autoimmune rheumatic diseases. Illustrations and images help present information in a clear and schematic way.

Download or read book Ketamine for Depression written by Dr. Stephen J. Hyde and published by Xlibris Corporation. This book was released on 2015-09-04 with total page 222 pages. Available in PDF, EPUB and Kindle. Book excerpt: Given the unacceptably high rates of suffering, disability and premature death experienced by people with treatment-resistant depression and the surprisingly low rates of problems arising from the use of ketamine to treat the disorder, this is a therapy that all patients and their doctors should be discussing. This book summarises the research that has been carried out into ketamine for the treatment of depression over the past 15 years and, most importantly, describes different ways of using ketamine that are both practical and cost–effective. Currently most ketamine therapy is given intravenously in specialised clinics at considerable expense, but the author has successfully treated patients with low-dose sublingual ketamine and his patients have been able to safely take this at home. Profits from the sales of this book will assist further research into the use of ketamine for the treatment of depression.

Download or read book Behavioral Neurogenetics written by John F. Cryan and published by Springer Science & Business Media. This book was released on 2012-05-04 with total page 637 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book covers a wide array of topics relevant to behavioral genetics from both a preclinical and clinical standpoint. Indeed in juxtaposing both areas of research the reader will appreciate the true translational nature of the field. Topics covered range from technical advances in genetic analysis in humans and animals to specific descriptions of advances in schizophrenia, attention disorders, depression and anxiety disorders, autism, aggression, neurodegeneration and neurodevelopmental disorders. The importance of gene-environment interactions is emphasised and the role of neuroimaging in unravelling the functional consequences of genetic variability described. This volume will be valued by both the basic scientist and clinician alike who may use it as a detailed reference book. It will also be of use to the novice to the field, to whom it will serve as an in-depth introduction to this exciting area of research.

Download or read book The Ketamine Papers written by Phil Wolfson and published by . This book was released on 2016-11 with total page 420 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Ketamine Papers opens the door to a broad understanding of this medicine's growing use in psychiatry and its decades of history providing transformative personal experiences. Now gaining increasing recognition as a promising approach to the treatment of depression, posttraumatic stress disorder (PTSD), and other psychological conditions, ketamine therapies offer new hope for patients and clinicians alike. With multiple routes of administration and practices ranging from anesthesia to psychotherapy, ketamine medicine is a diverse and rapidly growing field. The Ketamine Papers clarifies the issues and is an inspiring introduction to this powerful tool for healing and transformation--from its early use in the 1960s to its emerging role in the treatment of depression, suicidality, and other conditions. This comprehensive volume is the ideal introduction for patients and clinicians alike, and for anyone interested in the therapeutic and transformative healing power of this revolutionary medicine.

Download or read book Treatment resistant Mood Disorders written by Andre Carvalho and published by Oxford University Press, USA. This book was released on 2015 with total page 175 pages. Available in PDF, EPUB and Kindle. Book excerpt: Treatment-resistant major depression and bipolar disorder are highly prevalent and disabling conditions associated with substantial morbidity and mortality. Providing a concise view of the current definitions, assessment and evidence-based management of such disorders, this work reviews novel therapeutic targets, which may enhance the future therapeutic armamentarium of clinicians.

Download or read book Impact of the Coronavirus Pandemic COVID 19 on Mood Disorders and Suicide written by Paul Stokes and published by Frontiers Media SA. This book was released on 2022-02-28 with total page 401 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Suicide and self harm in young people written by Eve Griffin and published by Frontiers Media SA. This book was released on 2023-02-10 with total page 207 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Bridging the gap An interdisciplinary perspective on ketamine in psychiatric disorders written by Lucie Bartova and published by Frontiers Media SA. This book was released on 2023-09-07 with total page 99 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Comorbidity of Substance Use Disorders With Mental Health Disorders written by Christopher Jonathan Evans and published by Frontiers Media SA. This book was released on 2022-05-06 with total page 146 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Happy at Any Cost written by Kirsten Grind and published by Simon and Schuster. This book was released on 2023-03-14 with total page 320 pages. Available in PDF, EPUB and Kindle. Book excerpt: From award-winning Wall Street Journal reporters, “a startling portrait of one of our greatest tech visionaries, Zappos CEO Tony Hsieh” (Robert Kolker, author of Hidden Valley Road), reporting on his short life, untimely death, and what that means for our pursuit of happiness. Tony Hsieh—CEO of Zappos, Las Vegas developer, and beloved entrepreneur—was famous for spreading happiness. He lived and breathed this philosophy, instilling an ethos of joy at his company, outlining his vision for a better workplace in his New York Times bestseller Delivering Happiness. He promoted a workplace where bosses treated employees like family members, where stress was replaced by playfulness, and where hierarchies were replaced with equality and collaboration. His outlook shaped how we work today. Hsieh also aspired to build his own utopian cities, pouring millions of dollars into real estate and small businesses, first in downtown Las Vegas, Nevada—where Zappos is headquartered—and then in Park City, Utah. He gave generously to his employees and close friends, including throwing notorious Zappos parities and organizing gatherings at his home, an Airstream trailer park. When Hsieh died suddenly in late 2022, the news shook the business and tech world. Wall Street Journal reporters Kirsten Grind and Katherine Sayre discovered Hsieh’s obsession with happiness masked his darker struggles with addiction, mental health, and loneliness. In the last year of his life, he spiraled out of control, cycling out of rehab and into the waiting arms of friends who enabled his worst behavior, even as he bankrolled them from his billion-dollar fortune. Happy at Any Cost sheds light on one of our most creative, yet vulnerable, business leaders. It’s about our intense need to find “happiness” at all costs, our misguided worship of entrepreneurs, the stigmas still surrounding mental health, and how the trappings of fame can mask all types of deeper problems. In turn, it reveals how we conceptualize success—and define happiness—in our modern age.

Download or read book Drug Induced Liver Injury written by and published by Academic Press. This book was released on 2019-07-13 with total page 288 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series

Download or read book Social Isolation and Loneliness in Older Adults written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-05-14 with total page 317 pages. Available in PDF, EPUB and Kindle. Book excerpt: Social isolation and loneliness are serious yet underappreciated public health risks that affect a significant portion of the older adult population. Approximately one-quarter of community-dwelling Americans aged 65 and older are considered to be socially isolated, and a significant proportion of adults in the United States report feeling lonely. People who are 50 years of age or older are more likely to experience many of the risk factors that can cause or exacerbate social isolation or loneliness, such as living alone, the loss of family or friends, chronic illness, and sensory impairments. Over a life course, social isolation and loneliness may be episodic or chronic, depending upon an individual's circumstances and perceptions. A substantial body of evidence demonstrates that social isolation presents a major risk for premature mortality, comparable to other risk factors such as high blood pressure, smoking, or obesity. As older adults are particularly high-volume and high-frequency users of the health care system, there is an opportunity for health care professionals to identify, prevent, and mitigate the adverse health impacts of social isolation and loneliness in older adults. Social Isolation and Loneliness in Older Adults summarizes the evidence base and explores how social isolation and loneliness affect health and quality of life in adults aged 50 and older, particularly among low income, underserved, and vulnerable populations. This report makes recommendations specifically for clinical settings of health care to identify those who suffer the resultant negative health impacts of social isolation and loneliness and target interventions to improve their social conditions. Social Isolation and Loneliness in Older Adults considers clinical tools and methodologies, better education and training for the health care workforce, and dissemination and implementation that will be important for translating research into practice, especially as the evidence base for effective interventions continues to flourish.